pergolide - CISMeF

Preferred Label : pergolide;

MeSH definition : A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.;

CISMeF synonym : 66104-23-2 (Pergolide mesylate); elanco brand of pergolide mesylate; lilly brand of pergolide; lilly brand of pergolide mesylate; athena brand of pergolide mesylate; draxis brand of pergolide mesylate;

MeSH hyponym : LY-127809; pharken; permax; Pergolide Mesylate; Celance; Parkotil; LY127809; LY-127,809; LY127,809; Mesylate, Pergolide;

MeSH CAS label : ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-;

MeSH Related Number : pergolide mesylate; 66104-22-1 (Pergolide); 66104-23-2 (mesylate); 55B9HQY616;

Registry Number MeSH : 66104-22-1;

Related CAS MeSH : 55B9HQY616 (Pergolide mesylate);

Wikipedia link : https://en.wikipedia.org/wiki/Pergolide;

Is substance : O;

UNII : 24MJ822NZ9;

InChIKey : YEHCICAEULNIGD-MZMPZRCHSA-N;

Details

Origin ID

D010479;

UMLS CUI

C0031007;

ATC code(s)
- pergolide [ATC Code]
ATC code(s)
- pergolide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Pergolide [ICHI extension code]
- Pergolide Mesylate [International Nonproprietary Name]
- pergolide mesylate [Substance BNPC]
Currated CISMeF NLP mapping
- Pergolide [ICD-11 Extension code]
- Pergolide [LOINC component]
- Pergolide [NCIt concept]
- Pergolide (substance) [SNOMED CT concept]
Manual BTNT mappings - CISMeF
- Pergolide Mesylate [International Nonproprietary Name]
Pharmacological action(s)
- dopamine agonists [MeSH Descriptor]
Record concept(s)
- LY-127809 [MeSH concept]
- Pergolide Mesylate [MeSH concept]
- pergolide [MeSH concept]
- permax [MeSH concept]
- pharken [MeSH concept]
Related MeSH Supplementary Concept(s)
- 6-methyl-8-((methylthio)methyl)ergoline (8beta) [MeSH Supplementary Concept]
- 8-iodomethyl-6-propylergoline [MeSH Supplementary Concept]
- pergolide sulfone [MeSH Supplementary Concept]
- pergolide sulfoxide [MeSH Supplementary Concept]
- selenopergolide [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing pergolide (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Pergolide [LOINC component]
- Pergolide [ICD-11 Extension code]
- Pergolide [NCIt concept]
- Pergolide (substance) [SNOMED CT concept]
- Product containing pergolide (medicinal product) [SNOMED CT concept]
- pergolide [ATC Code]
Validated automatic mappings to BTNT
- Pergolide Mesylate [NCIt concept]
- Pergolide mesilate (substance) [SNOMED CT concept]
- pergolide [ATC Code]
- pergolide mesylate [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients